Director at OvaScience Inc. (NASDAQ:OVAS) F. Harald Stock recently acquired 1,063 shares of common stock, at a price of $7 per share. The stock was procured pursuant to a Rule 10b5-1 trading plan. Following this transaction, Mr. Stock holds 8,013 indirectly, by SB Vermogensverwaltungs KG, an investment company of which Mr. Stock is a majority shareholder and managing partner.
In the course of 2014, several insider transactions have been registered. Mr. Stock, in addition to the reported acquisition, made a 1,050 share purchase, at a price of $7.13 during the quarter. Moreover, directors and large shareholders Richard Aldrich and Christoph Westphal acquired 106,000 shares and 100,000 shares respectively during first two quarters. President And Chief Executive at OvaScience Inc. (NASDAQ:OVAS), Michelle Dipp, procured another 100,750 shares, and Large Shareholder Longwood Fund, L.P., acquired 100,000 as well.
Additionally, important hedge funds are feeling bullish about this stock. James E. Flynn’s Deerfield Management increased its stake by 176%, holding more than 1,6 million shares at the company, worth about $14 million, and accounting for 0.61% of the fund’s Equity Portfolio. Phill Gross And Robert Atchinson’s Adage Capital Management has decided to invest big as well, with 1,311,533 shares, valued at more than $11 million. Another important hedge fund, increasing its stake by 135% is Hal Mintz’s hedge fund, Sabby Capital, which currently holds above 300,000 shares, worth more than $3 million.